Crinetics Pharmaceuticals, a San Diego biotech focused on developing new drugs for endocrine disorders and endocrine-related cancers, said today it has raised $63.5 million in a Series B financing led by Perceptive Advisors, the New York biotech fund. Two new investors, RA Capital and OrbiMed, joined the round, along with existing investors 5AM Ventures, Versant […]